The study further demonstrates that neither cell-cycle progression nor neuronal maturity affects 5hmC levels at the FMR1 promoter, and TET enzyme expression levels do not differ significantly between FXS-derived neuronal models and primary neurons, suggesting that the lack of 5hmC enrichment in cellular models is not due to TET dysregulation. This evidence concerns the gene FMR1 and fragile X syndrome.